KG Capital Management Sells 1,666 Shares of HCA Healthcare, Inc. $HCA

KG Capital Management cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 63.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 963 shares of the company’s stock after selling 1,666 shares during the quarter. KG Capital Management’s holdings in HCA Healthcare were worth $411,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the business. BlackRock Inc. acquired a new stake in shares of HCA Healthcare in the second quarter worth $5,069,974,000. Wellington Management Group LLP lifted its position in HCA Healthcare by 20.5% during the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after purchasing an additional 799,761 shares during the period. Darsana Capital Partners LP boosted its holdings in HCA Healthcare by 46.7% in the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after purchasing an additional 350,000 shares during the last quarter. Legal & General Group Plc acquired a new stake in HCA Healthcare during the 2nd quarter worth about $410,992,000. Finally, Jupiter Topco LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at about $371,138,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Trading Up 2.1%

Shares of HCA opened at $470.25 on Thursday. The firm has a market cap of $101.81 billion, a P/E ratio of 15.51, a PEG ratio of 1.55 and a beta of 1.10. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The stock’s 50 day moving average is $424.28 and its two-hundred day moving average is $419.02.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the company posted $6.84 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 29.45 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th were issued a dividend of $0.78 per share. The ex-dividend date of this dividend was Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is presently 10.45%.

Analyst Ratings Changes

HCA has been the subject of several analyst reports. KeyCorp decreased their price objective on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a report on Monday, July 27th. Royal Bank Of Canada lifted their price target on HCA Healthcare from $435.00 to $496.00 and gave the company an “outperform” rating in a research report on Wednesday, October 7th. Raymond James Financial set a $528.00 price target on HCA Healthcare in a report on Tuesday, July 7th. Oppenheimer lowered their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research report on Monday, July 27th. Finally, Weiss Ratings raised shares of HCA Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $467.61.

About HCA Healthcare

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women’s and children’s care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.